Skip to main content
OpenTrials
Completed

NCT Number: NCT01264263

Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diabetes

This study is to investigate correlation between Carotid Intima Media Thickness (cIMT) and several factors such as; hs C-reactive protein (CRP), HbA1c, lipid profile in Korean diabetic patients with atherosclerosis. Total 360 patients will be enrolled through 6 sites.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Anyang, South Korea

Loading trial locations.

About this study

MC MD

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with Diabetic Mellitus
  • patients with dyslipidemia

Exclusion criteria

  • patients who have established cardiovascular disease
  • patient using NSAID

Treatment and study plan

Primary outcomes

  1. Measurement of intima media thickness, visit 1

    Time frame: Visit 1

  2. Measurement of intima media thickness, visit 2

    Time frame: Visit 2

Secondary outcomes

  1. hs-C-Reactive Protein, visit 1

    Time frame: Visit 1

  2. hs-C-Reactive Protein, visit 2

    Time frame: Visit 2

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: ALTO

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Dec 21, 2010
Registry last updated
Mar 13, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.